Citations (97)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Irl B. Hirsch. (2017) Professional flash continuous glucose monitoring as a supplement to A1C in primary care. Postgraduate Medicine 129:8, pages 781-790.
Read now
Read now
Articles from other publishers (96)
Manjae Kwon, Myeongjee Lee, Eun Hwa Kim, Dong-Woo Choi, Eunjin Jung, Keun You Kim, Inkyung Jung & Junghee Ha. (2023) Risk of depression and anxiety disorders according to long-term glycemic variability. Journal of Affective Disorders 343, pages 50-58.
Crossref
Crossref
Louis Monnier, Fabrice Bonnet, Claude Colette, Eric Renard & David Owens. (2023) Key indices of glycaemic variability for application in diabetes clinical practice. Diabetes & Metabolism 49:6, pages 101488.
Crossref
Crossref
Salma Ali El Chab Parolin, Rebecca Benicio Stocco, Julia do Carmo Kneipp Lopes, Marcos Roberto Curcio Pereira, Milena Massae Yamashita, Maria Eduarda Domareski Goulart, Henrique Demeneck, Marcia Olandoski, Larissa Hermann de Souza Nunes, Victor Keniche Morisawa, Luiz Augusto Fanhani Cracco, Isabela Busto Silva, Jarbas Silva Motta Júnior, Daniela Veit Barreto, Gustavo Lenci Marques, Thyago Proença de Moraes & Cristina Pellegrino Baena. (2023) Association between inpatient glycemic variability and COVID-19 mortality: a prospective study. Diabetology & Metabolic Syndrome 15:1.
Crossref
Crossref
Nicholas Berin Chan, Weizi Li, Theingi Aung, Eghosa Bazuaye & Rosa M Montero. (2023) Machine Learning–Based Time in Patterns for Blood Glucose Fluctuation Pattern Recognition in Type 1 Diabetes Management: Development and Validation Study. JMIR AI 2, pages e45450.
Crossref
Crossref
Ying Xie, Jin Lin, Martin Gallagher, Rinaldo Bellomo, Xia Wang, Meg Jardine, Meili Duan & Amanda Wang. (2022) Prognostic Significance of Baseline Blood Glucose Levels and Glucose Variability in Severe Acute Kidney Injury: A Secondary Analysis from the RENAL Study. Journal of Clinical Medicine 12:1, pages 15.
Crossref
Crossref
Evan Olawsky, Yuan Zhang, Lynn E Eberly, Erika S Helgeson & Lisa S Chow. (2021) A New Analysis Tool for Continuous Glucose Monitor Data. Journal of Diabetes Science and Technology 16:6, pages 1496-1504.
Crossref
Crossref
Sol Batule, Analía Ramos, Alejandra Pérez-Montes de Oca, Natalia Fuentes, Santiago Martínez, Joan Raga, Xoel Pena, Cristina Tural, Pilar Muñoz, Berta Soldevila, Nuria Alonso, Guillermo Umpierrez & Manel Puig-Domingo. (2022) Comparison of Glycemic Variability and Hypoglycemic Events in Hospitalized Older Adults Treated with Basal Insulin plus Vildagliptin and Basal–Bolus Insulin Regimen: A Prospective Randomized Study. Journal of Clinical Medicine 11:10, pages 2813.
Crossref
Crossref
Noppadol Kietsiriroje, Sam M Pearson, Lauren L O’Mahoney, Daniel J West, Robert AS Ariëns, Ramzi A Ajjan & Matthew D Campbell. (2022) Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study. Diabetes and Vascular Disease Research 19:3, pages 147916412211032.
Crossref
Crossref
Selcuk Dagdelen, Oguzhan Deyneli, Nevin Dinccag, Hasan Ilkova, Zeynep Osar Siva, Ilhan Yetkin & Temel Yilmaz. (2022) Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice. Frontiers in Endocrinology 12.
Crossref
Crossref
Ally McIllhatton, Sean Lanting, David Lambkin, Lucy Leigh, Sarah Casey & Vivienne Chuter. (2021) Reliability of recommended non-invasive chairside screening tests for diabetes-related peripheral neuropathy: a systematic review with meta-analyses. BMJ Open Diabetes Research & Care 9:2, pages e002528.
Crossref
Crossref
María Paula Russo, Santiago Nicolas Marquez Fosser, Cristina María Elizondo, Diego Hernán Giunta, Nora Angélica Fuentes & María Florencia Grande-Ratti. (2021) In-Hospital Mortality and Glycemic Control in Patients with Hospital Hyperglycemia. Review of Diabetic Studies 17:2, pages 50-56.
Crossref
Crossref
David Rodbard. (2021) Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy. Diabetes Technology & Therapeutics 23:10, pages 692-704.
Crossref
Crossref
Dinara Sheryazdanova & Yelena Laryushina. (2021) 1,5-Anhydroglucitol in type 2 diabetes mellitus patients with ST elevation myocardial infarction.. Journal of Clinical Medicine of Kazakhstan 18:4, pages 52-57.
Crossref
Crossref
Jean-Baptiste Julla, Pauline Jacquemier, Guy Fagherazzi, Tiphaine Vidal-Trecan, Vanessa Juddoo, Asma Jaziri, Hanane Mersel, Nicolas Venteclef, Ronan Roussel, Pascale Massin, Aude Couturier, Jean-François Gautier & Jean-Pierre Riveline. (2021) Is the Consensual Threshold for Defining High Glucose Variability Implementable in Clinical Practice?. Diabetes Care 44:7, pages 1722-1725.
Crossref
Crossref
Yifei Mo, Xiaojing Ma, Jingyi Lu, Yun Shen, Yufei Wang, Lei Zhang, Wei Lu, Wei Zhu, Yuqian Bao & Jian Zhou. (2020) Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes. Journal of Diabetes Investigation 12:6, pages 1025-1034.
Crossref
Crossref
Sara HallströmIrl B. HirschMagnus EkelundSheyda SofizadehHenrik AlbrektssonSolveig DahlqvistAnn-Marie SvenssonMarcus Lind. (2021) Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections. Diabetes Technology & Therapeutics 23:6, pages 425-433.
Crossref
Crossref
Thomas BlevinsWendy LaneDavid RodbardDana SindelarLudi FanKelly EllinorLiza IlagTrang LyJennal Johnson. (2021) Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study. Diabetes Technology & Therapeutics 23:1, pages 51-58.
Crossref
Crossref
Jee Hee Yoo & Jae Hyeon Kim. (2020) Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control. Diabetes & Metabolism Journal 44:6, pages 828-839.
Crossref
Crossref
Yongyu Ye, Baiqi Pan, Minghui Gu, Guoyan Xian, Weishen Chen, Linli Zheng, Ziji Zhang & Puyi Sheng. (2020) Fluctuation of fasting blood glucose in patients who underwent primary or revision total joint arthroplasty: a retrospective review. Journal of Orthopaedic Surgery and Research 15:1.
Crossref
Crossref
Mads N. Thomsen, Mads J. Skytte, Arne Astrup, Carolyn F. Deacon, Jens J. Holst, Sten Madsbad, Thure Krarup, Steen B. Haugaard & Amirsalar Samkani. (2020) The clinical effects of a carbohydrate-reduced high-protein diet on glycaemic variability in metformin-treated patients with type 2 diabetes mellitus: A randomised controlled study. Clinical Nutrition ESPEN 39, pages 46-52.
Crossref
Crossref
Guillermo Guzmán, Veline Martínez, Julián David Yara, Miguel Angel Mina, Juan Sebastian Solarte, Angela María Victoria & Karen Fériz. (2020) Glycemic Control and Hypoglycemia in Patients Treated with Insulin Pump Therapy: An Observational Study. Journal of Diabetes Research 2020, pages 1-8.
Crossref
Crossref
Michelle NguyenJulia HanElias K. SpanakisBoris P. KovatchevDavid C. Klonoff. (2020) A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control. Diabetes Technology & Therapeutics 22:8, pages 613-622.
Crossref
Crossref
David Rodbard. (2020) Glucose Time In Range, Time Above Range, and Time Below Range Depend on Mean or Median Glucose or HbA1c, Glucose Coefficient of Variation, and Shape of the Glucose Distribution. Diabetes Technology & Therapeutics 22:7, pages 492-500.
Crossref
Crossref
Simon Helleputte, Tine De Backer, Bruno Lapauw, Samyah Shadid, Bert Celie, Birgit Van Eetvelde, Karsten Vanden Wyngaert & Patrick Calders. (2020) The relationship between glycaemic variability and cardiovascular autonomic dysfunction in patients with type 1 diabetes: A systematic review. Diabetes/Metabolism Research and Reviews 36:5.
Crossref
Crossref
Si-jie Yuan & Jie Shen. (2020) Increased Preoperative Glucose Variability Is Associated with Adverse Perioperative Outcomes Following Orthopedic Surgery in Patients with Type 2 Diabetes Mellitus. Current Medical Science 40:3, pages 523-529.
Crossref
Crossref
Louis Monnier, Anne Wojtusciszyn, Nicolas Molinari, Claude Colette, Eric Renard & David Owens. (2020) Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?. Diabetes Care 43:4, pages 821-827.
Crossref
Crossref
Chao Shi, Si Liu, Hai-Feng Yu & Bin Han. (2020) Glycemic variability and all-cause mortality in patients with diabetes receiving hemodialysis: A prospective cohort study. Journal of Diabetes and its Complications 34:4, pages 107549.
Crossref
Crossref
Lalantha Leelarathna, Hood Thabit, Malgorzata E. Wilinska, Lia Bally, Julia K. Mader, Thomas R. Pieber, Carsten Benesch, Sabine Arnolds, Terri Johnson, Lutz Heinemann, Norbert Hermanns, Mark L. Evans & Roman Hovorka. (2019) Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index. Journal of Diabetes Science and Technology 14:2, pages 277-283.
Crossref
Crossref
Manon Jalbert, Fei Zheng, Anne Wojtusciszyn, Florence Forbes, Stéphane Bonnet, Kristina Skaare, Pierre-Yves Benhamou & Sandrine Lablanche. (2019) Glycemic variability indices can be used to diagnose islet transplantation success in type 1 diabetic patients. Acta Diabetologica 57:3, pages 335-345.
Crossref
Crossref
Daiki Kobayashi, Hiroshi Noto, Osamu Takahashi & Takuro Shimbo. (2020) Glycemic variability and subsequent malignancies among the population without diabetes. Diabetes Research and Clinical Practice 159, pages 107987.
Crossref
Crossref
Peter R. Dijk, Femke Waanders, Susan J. J. Logtenberg, Klaas H. Groenier, Titia M. Vriesendorp, Nanne Kleefstra, Harry Goor & Henk J. G. Bilo. (2019) Different routes of insulin administration do not influence serum free thiols in type 1 diabetes mellitus. Endocrinology, Diabetes & Metabolism 2:4.
Crossref
Crossref
Ana María GómezDiana Cristina HenaoAngélica Imitola MaderoLucía B. TaboadaViviana CruzMaría Alejandra Robledo GómezMartin RondónOscar Muñoz-VelandiaMaira García-JaramilloFabian Mauricio León Vargas. (2019) Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia. Diabetes Technology & Therapeutics 21:8, pages 430-439.
Crossref
Crossref
Amit Akirov, Tzipora Shochat, Idit Dotan, Talia Diker-Cohen, Alexander Gorshtein & Ilan Shimon. (2019) Glycemic variability and mortality in patients hospitalized in general surgery wards. Surgery 166:2, pages 184-192.
Crossref
Crossref
Ji Hee Yu, Kyungdo Han, Sanghyun Park, Da Young Lee, Ga Eun NamJi A Seo, Sin Gon Kim, Sei Hyun Baik, Yong Gyu Park, Seon Mee KimNan Hee Kim & Kyung Mook Choi. (2019) Effects of long-term glycemic variability on incident cardiovascular disease and mortality in subjects without diabetes. Medicine 98:29, pages e16317.
Crossref
Crossref
Nevena Chakarova, Rumyana Dimova, Greta Grozeva & Tsvetalina Tankova. (2019) Assessment of glucose variability in subjects with prediabetes. Diabetes Research and Clinical Practice 151, pages 56-64.
Crossref
Crossref
Valentino Cherubini, Rosaria Gesuita, Edlira Skrami, Ivana Rabbone, Riccardo Bonfanti, Claudia Arnaldi, Giuseppe D'Annunzio, Annapaola Frongia, Fortunato Lombardo, Elvira Piccinno, Riccardo Schiaffini, Sonia Toni, Stefano Tumini, Davide Tinti, Paola Cipriano, Nicola Minuto, Lorenzo Lenzi, Lucia Ferrito, Claudia Ventrici, Federica Ortolani, Ohad Cohen & Andrea Scaramuzza. (2019) Optimal predictive low glucose management settings during physical exercise in adolescents with type 1 diabetes. Pediatric Diabetes 20:1, pages 107-112.
Crossref
Crossref
A Atamna, G Ayada, A Akirov, T Shochat, J Bishara & Avishay Elis. (2019) High blood glucose variability is associated with bacteremia and mortality in patients hospitalized with acute infection. QJM: An International Journal of Medicine 112:2, pages 101-106.
Crossref
Crossref
Przemysław KucharskiKonrad PagaczAgnieszka SzadkowskaWojciech MłynarskiAndrzej RomanowskiWojciech Fendler. (2018) Resistance to Data Loss of Glycemic Variability Measurements in Long-Term Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 20:12, pages 833-842.
Crossref
Crossref
Guillermo E. Umpierrez & Boris P. Kovatchev. (2018) Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes. The American Journal of the Medical Sciences 356:6, pages 518-527.
Crossref
Crossref
Ana M. Gómez, Oscar M. Muñoz, Alejandro Marin, Maria Camila Fonseca, Martin Rondon, María Alejandra Robledo Gómez, Andrei Sanko, Dilcia Lujan, Maira García-Jaramillo & Fabian Mauricio León Vargas. (2018) Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus. Journal of Diabetes Science and Technology 12:5, pages 1007-1015.
Crossref
Crossref
Keiichi TorimotoYosuke OkadaMaiko HajimeKenichi TanakaYoshiya Tanaka. (2018) Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 20:9, pages 603-612.
Crossref
Crossref
Noam Shohat, Camilo Restrepo, Arash Allierezaie, Majd Tarabichi, Rahul Goel & Javad Parvizi. (2018) Increased Postoperative Glucose Variability Is Associated with Adverse Outcomes Following Total Joint Arthroplasty. Journal of Bone and Joint Surgery 100:13, pages 1110-1117.
Crossref
Crossref
Pennie J Taylor, Campbell H Thompson & Grant D Brinkworth. (2018) Effectiveness and acceptability of continuous glucose monitoring for type 2 diabetes management: A narrative review. Journal of Diabetes Investigation 9:4, pages 713-725.
Crossref
Crossref
Oscar M. Muñoz, Ana María Gómez, García-Jaramillo Maira, Leon-Vargas Fabián Mauricio & Álvaro J. Ruiz-Morales. (2018) The different methods of assessing glycemic variability, quality of glycemic control and glycemic risk cannot be interpreted as equivalent in clinical practice. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:4, pages 555-561.
Crossref
Crossref
Feng-fei Li, Bing-li Liu, Guo-ping Yin, Reng-na Yan, Dan-feng Zhang, Jin-dan Wu, Lei Ye, Xiao-fei Su & Jian-hua Ma. (2018) Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes. Scientific Reports 8:1.
Crossref
Crossref
David Rodbard. (2018) Glucose Variability: A Review of Clinical Applications and Research Developments. Diabetes Technology & Therapeutics 20:S2, pages S2-5-S2-15.
Crossref
Crossref
David Rodbard. (2018) Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with “Risk Indices”. Diabetes Technology & Therapeutics 20:5, pages 325-334.
Crossref
Crossref
Suresh Rama ChandranWei Lin TayWeng Kit LyeLee Ling LimJeyakantha RatnasingamAlexander Tong Boon TanDaphne S.L. Gardner. (2018) Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes. Diabetes Technology & Therapeutics 20:5, pages 353-362.
Crossref
Crossref
S. Borot, P.Y. Benhamou, C. Atlan, E. Bismuth, E. Bonnemaison, B. Catargi, G. Charpentier, A. Farret, N. Filhol, S. Franc, D. Gouet, B. Guerci, I. Guilhem, C. Guillot, N. Jeandidier, M. Joubert, V. Melki, E. Merlen, A. Penfornis, S. Picard, E. Renard, Y. Reznik, J.P. Riveline, S. Rudoni, P. Schaepelynck, A. Sola-Gazagnes, N. Tubiana-Rufi, O. Verier-Mine & H. Hanaire. (2018) Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement. Diabetes & Metabolism 44:1, pages 61-72.
Crossref
Crossref
Thomas A. PeyserAndrew K. BaloBruce A. BuckinghamIrl B. HirschArturo Garcia. (2018) Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data. Diabetes Technology & Therapeutics 20:1, pages 6-16.
Crossref
Crossref
Y. F. Mo & W. Jia. 2018. Continuous Glucose Monitoring. Continuous Glucose Monitoring
47
63
.
David C. Klonoff, David Ahn & Andjela Drincic. (2017) Continuous glucose monitoring: A review of the technology and clinical use. Diabetes Research and Clinical Practice 133, pages 178-192.
Crossref
Crossref
Feng-fei Li, Yun Shen, Rui Sun, Dan-feng Zhang, Xing Jin, Xiao-fang Zhai, Mao-yuan Chen, Xiao-fei Su, Jin-dan Wu, Lei Ye & Jian-hua Ma. (2017) Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes. Diabetes Therapy 8:5, pages 1111-1122.
Crossref
Crossref
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari & David R. Owens. (2017) Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes. Diabetes Care 40:7, pages 832-838.
Crossref
Crossref
Amit Akirov, Talia Diker-Cohen, Hiba Masri-Iraqi & Ilan Shimon. (2017) High Glucose Variability Increases Mortality Risk in Hospitalized Patients. The Journal of Clinical Endocrinology & Metabolism 102:7, pages 2230-2241.
Crossref
Crossref
Irl B. HirschAndrew K. BaloKevin SayerArturo GarciaBruce A. BuckinghamThomas A. Peyser. (2017) A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas. Diabetes Technology & Therapeutics 19:S3, pages S-38-S-48.
Crossref
Crossref
Feng-fei Li, Bing-li Liu, Reng-na Yan, Hong-hong Zhu, Pei-hua Zhou, Hui-qin Li, Xiao-fei Su, Jin-dan Wu, Dan-feng Zhang, Lei Ye & Jian-hua Ma. (2017) Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values. Scientific Reports 7:1.
Crossref
Crossref
E. Hommel, S. Schmidt, D. Vistisen, K. Neergaard, M. Gribhild, T. Almdal & K. Nørgaard. (2017) Effects of advanced carbohydrate counting guided by an automated bolus calculator in Type 1 diabetes mellitus (StenoABC): a 12-month, randomized clinical trial. Diabetic Medicine 34:5, pages 708-715.
Crossref
Crossref
Lorena Alarcon-Casas WrightIrl B. Hirsch. (2017) Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters. Diabetes Technology & Therapeutics 19:S2, pages S-16-S-26.
Crossref
Crossref
Robert J. Tanenberg, Sandra Hardee, Caitlin Rothermel & Almond J. Drake3rd3rd. (2017) Use of a Computer-Guided Glucose Management System to Improve Glycemic Control and Address National Quality Measures: A 7-Year, Retrospective Observational Study at A Tertiary Care Teaching Hospital. Endocrine Practice 23:3, pages 331-341.
Crossref
Crossref
L. Monnier. (2017) Réduire de manière concomitante l’exposition chronique au glucose et les fluctuations glycémiques dans le diabète de type 2 : Est-ce possible ?. Médecine des Maladies Métaboliques 11:2, pages 115-124.
Crossref
Crossref
Yunjiao J. Wang, Stacey Seggelke, R Matthew Hawkins, Joanna Gibbs, Mark Lindsay, Ingrid Hazlett, Cecilia C. Low Wang, Neda Rasouli, Kendra A. Young & Boris Draznin. (2016) Impact of Glucose Management Team on Outcomes of Hospitalization in Patients With Type 2 Diabetes Admitted to the Medical Service. Endocrine Practice 22:12, pages 1401-1405.
Crossref
Crossref
Dongli Xu, Hong Fang, Wanghong Xu, Yujie Yan, Yinan Liu & Baodong Yao. (2016) Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China. Scientific Reports 6:1.
Crossref
Crossref
Jean-Pierre Le Floch & Laurence Kessler. (2016) Glucose Variability. Journal of Diabetes Science and Technology 10:4, pages 885-891.
Crossref
Crossref
Soichi Takeishi, Akihiro Mori, Hiroki Hachiya, Takayuki Yumura, Shun Ito, Takashi Shibuya, Shintaro Hayashi, Nobutoshi Fushimi, Noritsugu Ohashi & Hiromi Kawai. (2015) Hypoglycemia and glycemic variability are associated with mortality in non‐intensive care unit hospitalized infectious disease patients with diabetes mellitus. Journal of Diabetes Investigation 7:3, pages 429-435.
Crossref
Crossref
Timothy S. Bailey, George. Grunberger, Bruce W. Bode, Yehuda. Handelsman, Irl B. Hirsch, Lois. Jovanovič, VictorLawrence. Roberts, David. Rodbard, William V. Tamborlane & John. Walsh. (2016) American Association Of Clinical Endocrinologists And American College Of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement. Endocrine Practice 22:2, pages 231-262.
Crossref
Crossref
. (2016)
Abstracts from ATTD 2016 9th International Conference on Advanced Technologies & Treatments for Diabetes
Milan, Italy–February 3–6, 2016
. Diabetes Technology & Therapeutics 18:S1, pages A-1-A-140.
Crossref
Crossref
David Rodbard. (2016) Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. Diabetes Technology & Therapeutics 18:S2, pages S2-3-S2-13.
Crossref
Crossref
Chiara Fabris, Andrea Facchinetti, Giuseppe Fico, Francesco Sambo, Maria Teresa Arredondo & Claudio Cobelli. (2015) Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis. Journal of Diabetes Science and Technology 10:1, pages 119-124.
Crossref
Crossref
Rudolf Chlup, Jan Krejci, Mark O'Connell, Blanka Sebestova, Robert Plicka, Lucie Jezova, Tereza Brozova, Blanka Doubravova, Hana Zalesakova, Emilia Durajkova, Jiri Vojtek & Josef Bartek. (2015) Glucose concentrations in blood and tissue - a pilot study on variable time lag. Biomedical Papers 159:4, pages 527-534.
Crossref
Crossref
Petra Augstein, Peter Heinke, Lutz Vogt, Roberto Vogt, Christine Rackow, Klaus-Dieter Kohnert & Eckhard Salzsieder. (2015) Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies. BMC Endocrine Disorders 15:1.
Crossref
Crossref
Boris Kovatchev, Guillermo Umpierrez, Andres DiGenio, Rong Zhou & Silvio E. Inzucchi. (2015) Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus. Journal of Diabetes Science and Technology 9:6, pages 1227-1235.
Crossref
Crossref
Nestoras Mathioudakis, Peter J. Pronovost, Sara E. Cosgrove, Daniel Hager & Sherita Hill Golden. (2015) Modeling Inpatient Glucose Management Programs on Hospital Infection Control Programs: An Infrastructural Model of Excellence. The Joint Commission Journal on Quality and Patient Safety 41:7, pages 325-336.
Crossref
Crossref
David Rodbard. (2015) Glycemic Variability: Challenges in Interpretation. Diabetes Technology & Therapeutics 17:6, pages 370-372.
Crossref
Crossref
Peter R. van DijkKlaas H. GroenierJ. Hans DeVriesReinold O.B. GansNanno KleefstraHenk J.G. BiloSusan J.J. Logtenberg. (2015) Continuous Intraperitoneal Insulin Infusion Versus Subcutaneous Insulin Therapy in the Treatment of Type 1 Diabetes: Effects on Glycemic Variability. Diabetes Technology & Therapeutics 17:6, pages 379-384.
Crossref
Crossref
S.-M. Jin, T.-H. Kim, S. Oh, J. Baek, J. Y. Joung, S.-M. Park, Y. Y. Cho, S. Y. Sohn, K. Y. Hur, M.-S. Lee, M.-K. Lee & J. H. Kim. (2015) Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring. Diabetic Medicine 32:2, pages 274-279.
Crossref
Crossref
Sunghwan SuhJae Hyeon Kim. (2015) Glycemic Variability: How Do We Measure It and Why Is It Important?. Diabetes & Metabolism Journal 39:4, pages 273.
Crossref
Crossref
Andrea Tura, Johan Farngren, Anja Schweizer, James E. Foley, Giovanni Pacini & Bo Ahrén. (2015) Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin. International Journal of Endocrinology 2015, pages 1-7.
Crossref
Crossref
Chiara FabrisAndrea FacchinettiGiovanni SparacinoMattia ZanonStefania GuerraAlberto MaranClaudio Cobelli. (2014) Glucose Variability Indices in Type 1 Diabetes: Parsimonious Set of Indices Revealed by Sparse Principal Component Analysis. Diabetes Technology & Therapeutics 16:10, pages 644-652.
Crossref
Crossref
S. Suh, J.Y. Joung, S.M. Jin, M.Y. Kim, J.C. Bae, H.D. Park, M.S. Lee, M.K. Lee & J.H. Kim. (2014) Strong correlation between glycaemic variability and total glucose exposure in type 2 diabetes is limited to subjects with satisfactory glycaemic control. Diabetes & Metabolism 40:4, pages 272-277.
Crossref
Crossref
Manuel Delgado Gómez. (2014) ¿Qué podemos esperar del control de la variabilidad glucémica?. Avances en Diabetología 30:3, pages 63-71.
Crossref
Crossref
Susan Shapiro Braithwaite. (2014) Multiplicative Standard Deviation for Blood Glucose. Diabetes Technology & Therapeutics 16:4, pages 195-197.
Crossref
Crossref
Laurent Crenier. (2014) Poincaré Plot Quantification for Assessing Glucose Variability from Continuous Glucose Monitoring Systems and a New Risk Marker for Hypoglycemia: Application to Type 1 Diabetes Patients Switching to Continuous Subcutaneous Insulin Infusion. Diabetes Technology & Therapeutics 16:4, pages 247-254.
Crossref
Crossref
Yoojin Kim, Kumar B. Rajan, Shannon A. Sims, Kristen E. Wroblewski & Sirimon Reutrakul. (2014) Impact of glycemic variability and hypoglycemia on adverse hospital outcomes in non-critically ill patients. Diabetes Research and Clinical Practice 103:3, pages 437-443.
Crossref
Crossref
Sunghwan SuhJae Hyeon Kim. (2014) Glucose Variability. The Journal of Korean Diabetes 15:4, pages 196.
Crossref
Crossref
Michael J Lanspa, Justin Dickerson, Alan H Morris, James F Orme, John Holmen & Eliotte L Hirshberg. (2014) Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin. Critical Care 18:2, pages R86.
Crossref
Crossref
Carlos E. Mendez, Ki-Tae Mok, Ashar Ata, Robert J. Tanenberg, Jorge Calles-Escandon & Guillermo E. Umpierrez. (2013) Increased Glycemic Variability Is Independently Associated With Length of Stay and Mortality in Noncritically Ill Hospitalized Patients. Diabetes Care 36:12, pages 4091-4097.
Crossref
Crossref
S. Inchiostro, R. Candido & F. Cavalot. (2013) How can we monitor glycaemic variability in the clinical setting?. Diabetes, Obesity and Metabolism 15:s2, pages 13-16.
Crossref
Crossref
Laurent Crenier, Charlotte Abou-Elias & Bernard Corvilain. (2013) Glucose Variability Assessed by Low Blood Glucose Index Is Predictive of Hypoglycemic Events in Patients With Type 1 Diabetes Switched to Pump Therapy. Diabetes Care 36:8, pages 2148-2153.
Crossref
Crossref
J. Hans DeVries. (2013) Glucose Variability: Where It Is Important and How to Measure It. Diabetes 62:5, pages 1405-1408.
Crossref
Crossref
Patrizio Tatti, Felice Strollo & Desiderio Passali. (2013) Sleep Apnea, Sleep Disturbance, and Fasting Glucose Variability: A Pilot Study. Journal of Diabetes Science and Technology 7:3, pages 743-748.
Crossref
Crossref
David Rodbard. (2013) Standardization Versus Customization of Glucose Reporting. Diabetes Technology & Therapeutics 15:5, pages 439-443.
Crossref
Crossref
Susan S. Braithwaite. (2012) Glycemic Variability in Hospitalized Patients: Choosing Metrics While Awaiting the Evidence. Current Diabetes Reports 13:1, pages 138-154.
Crossref
Crossref
David Rodbard. (2012) Hypo- and Hyperglycemia in Relation to the Mean, Standard Deviation, Coefficient of Variation, and Nature of the Glucose Distribution. Diabetes Technology & Therapeutics 14:10, pages 868-876.
Crossref
Crossref
David Rodbard. (2012) The Challenges of Measuring Glycemic Variability. Journal of Diabetes Science and Technology 6:3, pages 712-715.
Crossref
Crossref
David Rodbard. (2011) Glycemic Variability: Measurement and Utility in Clinical Medicine and Research—One Viewpoint. Diabetes Technology & Therapeutics 13:11, pages 1077-1080.
Crossref
Crossref